View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
TREAS/IRS RIN: 1545-BR16 Publication ID: Spring 2024 
Title: ●Branded Prescription Drug Fee Discounts 
Abstract:

The proposed regulation updates 51.4(b)(2)(i)(B) and (iv) of the Branded Prescription Drug Fee Regulations, which currently cite to the Coverage Gap Discount Program described in section 1860D-14A of the SSA (42 U.S.C. 1395w-114a), to reflect that the Inflation Reduction Act terminated this program and replaced it with the Manufacturer Discount Program described in section 1860D-14C of the SSA (42 U.S.C. 1395w-114c). The proposed regulations would also update 51.11 to reflect the applicability date for proposed 51.4(b)(2)(i)(B) and (iv).

 
Agency: Department of the Treasury(TREAS)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 26 CFR part 51 (Revision)     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: Pub. L. 117-169, sec. 11201    26 U.S.C. 7805   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  07/00/2024 
Additional Information: Drafting attorney: Camille Edwards Bennehoff, (202) 317-4905 Reviewing Attorney: Charles Langley, (202) 317-5274 Treasury Attorney: Vivek Chandrasekhar, (202) 622-1082 and Elisabeth Shellan (202) 622-1727 CC: PSI REG-103430-24
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Related RINs: Related to 1545-BJ39 
Agency Contact:
Camille L Edwards Bennehoff
Attorney
Department of the Treasury
Internal Revenue Service
1111 Constitution Avenue, NW, Room 5317,
Washington, DC 20224
Phone:202 317-4905
Email: camille.l.edwardsbennehoff@irscounsel.treas.gov